A human-human hybridoma secreting anti-Pseudomonas aeruginosa exotoxin-A monoclonal antibody with highly potent neutralizing activity
- PMID: 1369271
- DOI: 10.1007/BF00365263
A human-human hybridoma secreting anti-Pseudomonas aeruginosa exotoxin-A monoclonal antibody with highly potent neutralizing activity
Abstract
A hybridoma secreting human monoclonal antibody (MAB) against Pseudomonas aeruginosa exotoxin A (PEA) was constructed by fusing Epstein-Barr virus-transformed peripheral blood lymphocytes with human B lymphoblastoid cell line TAW-925. The human-human hybridoma stably produced human IgG2 MAB at the rate of 0.4-0.5 microgram/ml per 10(6) cells per day for more than six months, and the MAB was capable of neutralizing the in vitro cytotoxic and in vivo lethal effects of PEA with approximately 100- and 70-fold, respectively, higher activity than serum polyclonal antibody preparations.
Similar articles
-
A human hybrid hybridoma producing a bispecific monoclonal antibody that can target tumor cells for attack by Pseudomonas aeruginosa exotoxin A.Cytotechnology. 1990 Jul;4(1):59-68. doi: 10.1007/BF00148811. Cytotechnology. 1990. PMID: 1369279
-
Production and characterization of human monoclonal antibody recognizing the N-terminal residues of Pseudomonas aeruginosa exotoxin A.Hybridoma. 1991 Apr;10(2):297-307. doi: 10.1089/hyb.1991.10.297. Hybridoma. 1991. PMID: 1651902
-
A Pseudomonas aeruginosa alginate-exotoxin A conjugate that elicits anti-alginate and exotoxin A-neutralizing antibodies.FEMS Microbiol Immunol. 1991 Aug;3(4):185-92. doi: 10.1111/j.1574-6968.1991.tb04213.x. FEMS Microbiol Immunol. 1991. PMID: 1931130
-
The role of exotoxin A in pseudomonas disease and immunity.Rev Infect Dis. 1983 Nov-Dec;5 Suppl 5:S979-84. doi: 10.1093/clinids/5.supplement_5.s979. Rev Infect Dis. 1983. PMID: 6419320 Review.
-
Use of Pseudomonas aeruginosa toxin A in the construction of conjugate vaccines and immunotoxins.Rev Infect Dis. 1987 Sep-Oct;9 Suppl 5:S644-9. doi: 10.1093/clinids/9.supplement_5.s644. Rev Infect Dis. 1987. PMID: 3120274 Review.
Cited by
-
A human hybrid hybridoma producing a bispecific monoclonal antibody that can target tumor cells for attack by Pseudomonas aeruginosa exotoxin A.Cytotechnology. 1990 Jul;4(1):59-68. doi: 10.1007/BF00148811. Cytotechnology. 1990. PMID: 1369279
-
Recent developments for Pseudomonas vaccines.Hum Vaccin. 2011 Oct;7(10):999-1011. doi: 10.4161/hv.7.10.16369. Epub 2011 Oct 1. Hum Vaccin. 2011. PMID: 21941090 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials